Loading lessons…
Peptide learning paths
Learn peptides step by step
Curated lessons across 8 learning paths — from first concepts to trial summaries and practical protocols. Pick your level, follow the curriculum, and build real understanding.
Where are you starting?
272lessons
8paths
0day streak
0%explored
Start your first lesson
Choose a learning path below or search the library. Progress saves in your browser.
Prefer timeline chaos? Peptide X Quiz · Literacy certify
Learning paths
Pick a track — progress rings update as you complete lessons.
12 lessons
9mProtocolsIntermediate
Tesamorelin Reconstitution and Dosing: What Labeled Use and Papers Report
Tesamorelin is one of the few GHRH analogs with an FDA-labeled daily milligram figure. That number belongs to a specific product and indication. It does not automatically travel to an unlabeled vial.
9mPeptidesIntermediate
Tesamorelin's Clinical Utility: Why Waist, Liver Fat, and IGF-1 Belong Together
Tesamorelin makes more sense when you track the body it changes, not just the number on the scale. Waist, liver fat, IGF-1, and lean mass tell the real story.
12mProtocolsIntermediate
Retatrutide and Tesamorelin Together: What the Stack Question Really Means
Reta plus Tesa is one of the most asked stack questions in 2026. This guide explains why people combine metabolic and visceral-fat peptides, what to track, and why same-syringe mixing is usually avoided.
8mResearchAdvanced
Tesamorelin and Waist-First Tracking: The Metrics That Matter Most
Tesamorelin is a body-composition tool, not a bathroom-scale trick. The best results show up when you track the right metrics from the start.
9mResearchAdvanced
The GH-IGF1 Axis Still Explains the Best Peptide Performance Stories
The GH-IGF1 axis keeps showing up in peptide medicine because it links visceral fat, recovery, and lean mass. The trick is separating the clinical signal from the wellness noise.
9mResearchAdvanced
Tesamorelin and Liver Fat: Why the TESA-LIVER Trial Matters
Tesamorelin has one of the cleanest human-data stories in the peptide space. The new liver fat trial matters because it asks whether that signal extends into fatty liver disease.
8mResearchAdvanced
Retatrutide and Visceral Fat: Why the Scale Misses the Real Signal
Scale weight is noisy. If you are using retatrutide, waist trend, body composition, protein intake, and strength matter more than a single weigh-in.
8mResearchAdvanced
Tesamorelin and Visceral Fat: What the 2026 Meta-Analysis Shows
Tesamorelin has one of the stronger human-data profiles in the peptide space. A 2026 meta-analysis helps clarify what it improves, what it does not, and how to track the signal honestly.
9mProtocolsIntermediate
Stacking Tesamorelin and MOTS-C with Retatrutide: A Complete Protocol Guide
Already on Reta and ready to add compounds? Here's how to stack Tesamorelin and MOTS-C with Retatrutide for maximum fat loss and recomp.
10mProtocolsIntermediate
5-Amino-1MQ: The NNMT Inhibitor That Stacks With GLP-1s and MOTS-C
Most fat-loss compounds either suppress appetite or boost energy expenditure. 5-Amino-1MQ does something different — it blocks the enzyme that burns through your NAD+ and keeps fat cells from ever getting broken down. Here's why it stacks so well with Reta and MOTS-C.
9mPeptidesIntermediate
Tesamorelin: The Science-Backed Growth Hormone Peptide for Fat Loss and Longevity
Tesamorelin is an FDA-approved GHRH analog with clinical trials proving 15–20% visceral fat reduction. Here's the full science, dosing guide, and what the latest research reveals about its longevity applications.
8mPeptidesIntermediate
Tesamorelin: The FDA-Approved Peptide for Visceral Fat Reduction
Discover Tesamorelin, the only FDA-approved GHRH peptide, specifically indicated for reducing visceral fat.
Also available at /blog for legacy links.